FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Original Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved Chartwell RX, LLC's original ANDA for the generic fixed-dose combination triamterene/hydrochlorothiazide.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Edema
• Hypertension

Drugs mentioned

• Triamterene and Hydrochlorothiazide (Triamterene and hydrochlorothiazide)

Snippet

ORIG AP for TRIAMTERENE AND HYDROCHLOROTHIAZIDE (TRIAMTERENE AND HYDROCHLOROTHIAZIDE)